Important Legal Notice for MacroGenics Investors
The Gross Law Firm is reaching out to shareholders of MacroGenics, Inc. (NASDAQ: MGNX) to share vital information about a class action lawsuit that could impact your investments.
Class Period Details
If you bought shares of MacroGenics during the specified period from March 7, 2024, to May 9, 2024, it's important to get in touch with the firm. You don’t need to be a lead plaintiff to be part of any potential recovery.
Why This Lawsuit Matters
This class action arises from claims that MacroGenics provided false safety data about its drug, vobramitamab duocarmazine. The company came under fire when it was revealed that the drug posed risks significantly higher than they had initially acknowledged. After this news broke on May 9, 2024, the stock price fell sharply by 77.4%, which translates to a loss of $11.36 per share, significantly affecting shareholders.
Upcoming Registration Deadline
The last day to register as a claimant in this class action is September 24, 2024. If you're a shareholder within the designated class period, it's crucial not to postpone your registration.
Benefits of Shareholder Participation
By registering, you'll gain access to a portfolio monitoring system that keeps you informed about the progress of the case. It’s essential to note that there are no costs involved for you to participate in this lawsuit.
About The Gross Law Firm
The Gross Law Firm is a nationally recognized class action law firm committed to protecting investors' rights who have experienced losses due to deceitful practices and false representations. Their mission is to hold corporations accountable for maintaining responsible practices and adhering to ethical standards. They focus on recovering losses for investors affected by misleading or omitted information that inflated a company’s stock prices. Keep in mind that past outcomes do not guarantee future results.
Contact Information
If you have any questions about the class action or need assistance:
The Gross Law Firm
15 West 38th Street, 12th Floor
New York, NY 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
Frequently Asked Questions
What is the class action lawsuit about?
The class action lawsuit concerns allegations that MacroGenics provided misleading safety data for its drug, leading to substantial losses for investors.
Who can participate in the class action?
Any shareholders who purchased MGNX shares between March 7, 2024, and May 9, 2024, are eligible to join this class action lawsuit.
What is the deadline for registration?
You must register for this class action by September 24, 2024. Be sure to complete your registration before this deadline.
What are the risks associated with this lawsuit?
Joining this class action incurs no financial cost or obligation. However, it is vital for shareholders to act promptly because the registration deadline is fast approaching.
How does the Gross Law Firm assist investors?
The Gross Law Firm offers legal support and case monitoring for investors who have suffered financial losses due to deceptive corporate behaviors.